PTC Therapeutics, Inc. PTCT
68.12 USD +7.24 (+11.89%)
At closeNov 3, 2026, 4:00 PM EST
68.12 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
63.16 Day range 68.72
58.80 52-week range 90.87
- YTD
- -10.32%
- 1 year
- +0.28%
Analyst view
Consensus: buy
Buy
Price target (mean) 100.47 +47.5% upside
Now 68.12
- Target (low)
- 62.00
- Target (mean)
- 100.47
- Target (high)
- 137.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
- Strong buy4
- Buy9
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 14
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.14 | 0.13 – 0.15 | -1.80 | +107.8% | 330.38M | +100.6% | 2 |
| Next quarter | 0.49886 | -0.01 – 1.38 | -0.03 | +1762.9% | 313.41M | +15.0% | 7 |
| Current year | 0.935 | 0.73 – 1.14 | 7.62 | -87.7% | 1.32B | -23.7% | 2 |
| Next year | 2.43 | 1.82 – 3.04 | 0.935 | +159.9% | 1.43B | +8.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Sep 22, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 20, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| May 27, 2026 | Jefferies | Upgrade | Hold | Buy |
| May 8, 2026 | TD Cowen | Upgrade | Hold | Buy |
| May 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 30, 2026 | Jefferies | Downgrade | Buy | Hold |
| Feb 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Feb 20, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 20, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Feb 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jan 28, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Dec 1, 2025 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Nov 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 5, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Nov 5, 2025 | TD Cowen | Maintained | Hold | Hold |
| Nov 5, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 5, 2025 | Goldman Sachs | Maintained | Sell | Sell |
| Nov 5, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
